Risky detox tool
Flumazanil is currently not recommended to treat chronic benzodiazepines by the American College of Medical Toxicology.
There is a very real risk that rapid reversal of benzodiazepines can lead to refractory seizures only treatable with barbiturates as flumazanil binds to GABA
receptors with greater affinity, which could lead to unopposed glutamate
tapers are better